Peptide-mediated delivery of therapeutic mRNA in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptide-mediated delivery of therapeutic mRNA in ovarian cancer

Published:2019-08 Issue: Volume:141 Page:180-190
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

van den Brand Dirk,Gorris Mark A.J.,van Asbeck Alexander H.,Palmen Emma,Ebisch Inge,Dolstra Harry,Hällbrink Mattias,Massuger Leon F.A.G.,Brock Roland

Funder

Netherlands Organisation for Scientific Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference63 articles.

1. Global cancer statistics, 2012: Global Cancer Statistics, 2012;Torre;CA: Cancer J. Clin.,2015

2. Ovarian cancer;Jayson;The Lancet,2014

3. The role of Cediranib in ovarian cancer;Orbegoso;Exp. Opin. Pharmacother.,2017

4. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA Open-Label Randomized Phase III Trial;Pujade-Lauraine;J. Clin. Oncol.,2014

5. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial;Oza;Lancet Oncol.,2015

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and prospects of RNA delivery nanoplatforms for cancer therapy;Acta Pharmaceutica Sinica B;2024-09

2. Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats;World Journal of Diabetes;2024-08-15

3. Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems;Molecular Pharmaceutics;2024-07-02

4. N‐terminal modification of an LAH4‐derived peptide increases mRNA delivery in the presence of serum;Journal of Peptide Science;2024-03-25

5. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond;Advanced Drug Delivery Reviews;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3